Delivery Order SPE2DB20D2104-SPE2DB22FR70T
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,783.97 firm fixed-price delivery order is for the supply of HYZAAR 100-25 tablets, with a period of performance through January 17, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,282.66 firm fixed-price delivery order is for the supply of HYZAAR 100-25 tablets to the DLA. The award has an ultimate completion date of March 4, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is a firm fixed price delivery order between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The award is for the supply of HYZAAR 50-12.5 TABLET 30S, a pharmaceutical product, with a potential value of $1,102.08 and a completion date of February 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,000.86 firm fixed-price delivery order is for the supply of HYZAAR 100-25 TABLET 30S, a pharmaceutical product, to support military and government healthcare programs. The award is not designated with a set-aside requirement, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant...
- This federal contract award is for the delivery of HYZAAR 100-12.5 TABLET 30S medication, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $9,635.71 firm fixed-price delivery order contract has a completion date of November 21, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and...
- This federal contract award, valued at $10,809.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award is for the delivery of HYZAAR 100-25 TABLET 30S (NSN 4564885775) to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds several other federal contracts with agencies like the Department of Justice. The contract is a Delivery Order with a Firm Fixed Price of $2,934.16 and has an ultimate completion date of June 13, 2024. It...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,416.58 to AmerSourceBergen Drug Corp on January 8, 2026, for the supply of Hyzaar 100-25 tablets (30-count packages). This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies a completion date of January 9, 2026. The pharmaceutical product will be delivered to AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the drug Hyzaar 50-12.5 Tablet 30s, with a ceiling value of $9,966.62 and a completion date of December 22, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The $2,275.00 firm-fixed price delivery order is for the supply of HYZAAR 100-25 Tablets (30 count) to support DLA's medical supply requirements. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the main...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FR70TDelivery Order
This federal contract award is for the delivery of Hyzaar 100-25 tablets to the Defense Logistics Agency (DLA). The $7,654.47 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 1, 2022 with a completion date of February 2, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System for Award Management (SAM.gov) as a for-profit organization. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 2/1/22 |